Course Listings: Hematology

All Results (9)
Format: Live Events (0) Online Activities (9)

Beyond the Horizon: The Promise of Novel Therapies for Relapsed/Refractory DLBCL

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This accredited CME publication explores emerging treatment strategies for diffuse large B-cell lymphoma (DLBCL), including their mechanisms of action, efficacy data, and safety data; it also discusses novel therapies in clinical development for relapsed/refractory DLBCL. Additionally, expert faculty offer their perspectives on the integration of emerging…More


Recent Advances in the Management of Gaucher Disease Type 3

View Course

Format: Presentation Points

Maximum Credits: 0.5

Course Description: This transcript-based, CME-accredited Presentation Points publication highlights key points from a satellite symposium presented by nationally renowned experts on Gaucher disease type 3 (GD3) Pramod K. Mistry, MD, PhD, FRCP, and Raphael Schiffmann, MD, MHSc, FAAN. Faculty review the diagnostic potential of various investigational GD3 biomarkers and provide…More


Incorporating the Latest Therapeutic Advances and Shared Decision Making Into Clinical Practice

View Course

Format: Audiocast

Maximum Credits: 0.5

Course Description: This 30-minute audiocast discusses the treatment of patients with advanced classical Hodgkin lymphoma (cHL), with a focus on novel therapeutic strategies both in first-line and refractory/relapsed settings. In addition, brief clinical case vignettes are included to illustrate how disease-, treatment-, and patient-related factors affect management decisions.


Optimizing Patient-Centered cHL Care: Prompt Recognition and Management of Adverse Events and Empowering Patients

View Course

Format: Audiocast

Maximum Credits: 0.5

Course Description: This 30-minute audiocast discusses best practices in the management of treatment toxicities in patients with advanced classical Hodgkin lymphoma (cHL), along with strategies to educate and support patients throughout the continuum of care. Brief clinical case vignettes are included to illustrate strategies for monitoring for and managing adverse events.


Advances in Breast Cancer

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: This 30-minute webcast reviews recent updates and current clinical evidence in breast cancer management, including the latest surgical techniques, the use of genomic medicine in HR+/HER2- early stage breast cancer, and radiotherapy fractionation for early stage breast cancer.


Advances in the Management of Brain Metastases

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty review recent advances in the management of brain malignancies. In particular, April K.S. Salama, MD, discusses the current understanding of systemic therapy, John Kirkpatrick, MD, PhD, discusses advances in radiation therapy, and Peter Fecci, MD, PhD, discusses surgical improvements for brain metastasis.


Recent Advances in the Treatment of Hematologic Malignancies

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty explore recent advances in the treatment of hematologic malignancies. In particular, CAR T-cell therapy for relapsed and refractory diffuse large B-cell lymphoma and FLT3-targeted treatment in AML are discussed.


GFR and eGFR: Filtering Out the Confusion

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: Nephrologist Dr. Michael Wiederkehr delves into chronic kidney disease (CKD) and the difference between true glomerular filtration rate (GFR) and estimated glomerular filtration rate (eGFR). The different methods of calculating eGFR will be explored as well as the pitfalls and limitations of the current formulas and calculations. The importance of the CKD…More


Decision-IQ: Assessing Risk and Preventing Tumor Lysis Syndrome

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This brief case-based, digital CME activity incorporates current evidence-based prophylaxis algorithms to assess the risk of tumor lysis syndrome (TLS) in a patient with chronic lymphocytic leukemia (CLL) undergoing anticancer therapy. Links to relevant literature and expert insights are provided to help clinicians prevent and manage TLS.